MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion by Elson-Schwab, Ilan et al.
MicroRNA-200 Family Members Differentially Regulate
Morphological Plasticity and Mode of Melanoma Cell
Invasion
Ilan Elson-Schwab, Anna Lorentzen, Christopher J. Marshall*
Cancer Research UK Centre for Cell and Molecular Biology, Institute of Cancer Research, London, United Kingdom
Abstract
Background: A functional role of microRNAs (miRNAs or miRs) in neoplasia and metastasis is becoming clear, and the miR-
200 family has received much attention for potentially regulating tumor progression. The miRNAs of this family have been
shown to suppress epithelial-mesenchymal transition, and their down-regulation in some tumors promotes invasion and
metastasis. Interestingly, while miR-200 is down-regulated in some cancers, it is up-regulated in others.
Principal Findings: We show that levels of miR-200 are increased in melanoma cell lines compared to normal melanocytes
and that miR-200 family members play a role in determining modes of tumor cell migration. Individual tumor cells can
invade in either elongated, ‘‘mesenchymal-type’’ or rounded, ‘‘amoeboid-like’’ modes and these two modes of invasion are
inter-convertible [1]. In melanoma cell lines, expression of miR-200 members does not suppress invasion but rather leads to
a switch between modes of invasion. MicroRNA-200c results in a higher proportion of cells adopting the rounded,
amoeboid-like mode of invasion, while miR-200a results in a protrusion-associated elongated mode of invasion. Functional
target identification studies suggest that the morphological effects of miR-200c may be mediated by reduced expression of
MARCKS, which has been linked to formation of cell protrusions. In contrast miR-200a reduces actomyosin contractility, a
feature of rounded morphology.
Significance: Overall our findings call into question the general role of miR-200 in suppressing invasion and metastasis, and
highlight novel distinguishing characteristics of individual miR-200 family members.
Citation: Elson-Schwab I, Lorentzen A, Marshall CJ (2010) MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma
Cell Invasion. PLoS ONE 5(10): e13176. doi:10.1371/journal.pone.0013176
Editor: Erik H. J. Danen, Leiden University, Netherlands
Received April 13, 2010; Accepted September 5, 2010; Published October 4, 2010
Copyright:  2010 Elson-Schwab et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Cancer Research UK. C.J.M. is a Cancer Research UK Gibb Life Fellow. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: chris.marshall@icr.ac.uk
Introduction
Melanoma is a highly aggressive human cancer refractory to
most treatments. Progression from benign hyperplastic melano-
cytes to more aggressive disease occurs when tumor cells begin to
break down and invade through the basement membrane, and
subsequently migrate into the collagen-rich dermis [2]. It has
become clear that cancer cells have multiple modes of cell
migration during tissue invasion: collective, individual elongated
or ‘‘mesenchymal-type,’’ and individual rounded or ‘‘amoeboid-
type’’ [1,3,4]. The latter two modes of individual cell migration are
determined in large part by the balance of Rho and Rac small
GTPase signalling. The mesenchymal mode is driven by Rac
activation, and involves extensive protrusions and proteolytic
activity [1]. The rounded ‘‘amoeboid-type’’ on the other hand is
associated with a high degree of actomyosin contractility,
membrane blebbing and squeezing through matrices. The
amoeboid mode is favored by high Rho/ROCK signalling to
elevate actomyosin contractility [1] and is not dependent on
extracellular protease activity [4]. Importantly, there is negative
feedback between these two signalling pathways, with Rho-kinase
inhibiting the mesenchymal mode and Rac inhibiting the rounded
form of migration [1]. This interplay allows for dynamic signalling
and survival pathway dependence, and plasticity or switching
between different morphologies allows cancer cells to invade using
distinct pathways to adapt to different environments [4].
Cancer cell morphology can be modulated by microRNA
(miRNA or miR) activity [5,6,7]. MicroRNAs are 20–24
nucleotide non-coding RNAs that regulate gene expression by
targeting the 39 untranslated region of target mRNA transcripts
for degradation and/or translation inhibition. Target specificity is
directed by sequence complementarity to the microRNA -
particularly in the 29-89 seed region - and families have been
identified based on miRs that have highly similar or identical seed
sequences [8]. Of particular interest in the field of metastasis, the
miR-200 family has been shown to regulate epithelial-mesenchy-
mal transition (EMT) and cell migration in a variety of cancer cell
lines: miR-200a, -200b, -200c and -141 promote E-cadherin-based
junction formation and inhibit cell migration in Boyden-type
transwell chambers [9,10,11,12]. It appears that the miR-200
family is targeting Zeb transcriptional regulators [5], particularly
Zeb1 [9,10,11,12,13], preventing the repression of E-cadherin
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in more aggressive metaplastic breast as compared with ductal
tumors [10], and EMT is associated with disruption of cell-cell
adhesion and the acquisition of migratory behavior, it has been
suggested that the miR-200 down-regulation is involved with the
progression of cancer through promoting EMT and cell invasion.
However, while the expression of miR-200 family members is
down-regulated in some types of cancer, these microRNAs are
over-expressed in other cancers such as melanoma [14,15,16],
ovarian [17] and colorectal cancers [18]. For example, miR-200c
is up-regulated in melanoma lines compared to normal melano-
cytes [14] and in primary melanoma as compared to benign nevi
[16]. Additionally, analysis of microRNA levels showed that miR-
200c was up-regulated in melanoma metastases to the lung,
although down-regulated in those to the brain, as compared to
primary lesions [15]. Taken together, this data suggests that miR-
200c is differentially regulated in melanoma and may play a role in
disease initiation and/or progression.
In order to investigate the functional effects of the miR-200
family in melanoma, we decided to test whether expression of
miR-200 family members affects the ability of melanoma cells to
engage in morphological switching and use different modes of
migration to invade into a physiologic 3D collagen-I matrix. We
confirmed that miR-200 members are up-regulated in melanoma,
show they do not suppress invasion into 3D matrices and
sometimes increase invasive capacity. Interestingly, while elevation
of miR-200a levels led to the mesenchymal mode of cell migration,
elevation of miR-200c levels led to the amoeboid mode of
migration, highlighting new roles of this microRNA family in
switching or plasticity of modes of tumor cell migration.
Results
microRNA-200 family members regulate modes of
invasion in melanoma cells
Individual members of the miR-200 family can be subdivided in
two different ways according to genomic location or primary
sequence (Fig. 1A). We selected for our studies miR-200a and -
200c because each represents distinct subclasses according to seed
sequence and genomic location. In order to examine expression of
miR-200 members in melanoma, we examined expression of miR-
200a and -200c using quantitative PCR in a panel of melanoma
cell lines compared to normal human melanocytes using miR-30b*
as a control as we found its levels were relatively invariant across
the melanocytes and melanoma cell line panel (Fig. S1). For these
studies the cells were plated on a thick deformable layer of
collagen-I because this substrate mimics aspects of a true 3D
matrix and represents a more physiologic environment for studies
of melanoma cell migration [1]. We have previously shown cell
behaviour on this matrix closely correlates with results obtained
with invasion assays into a 3-dimensional matrix [1]. As shown in
Figure 1B, many of the melanoma lines examined had significantly
higher levels of both microRNAs than primary normal human
melanocytes plated on the same matrix.
Many studies have shown that miR-200 family members inhibit
cancer cell migration [9,10,11,12]. Melanoma cell invasion in vivo
is influenced by cell morphology and switching between different
modes of invasion [1,19]. The rounded ‘‘amoeboid’’ form of
movement seen in vivo is not revealed by assays of cell migration on
rigid 2D substrates, or transwell assays where cells have to migrate
through pores coated with a thin layer of extra-cellular matrix [3,4].
Hence in order to examine cellular morphology of invading cells,
various melanoma lines (Wm1361, Wm266.4 and Sbcl2) were
either mock transfected or transfected with scrambled control, miR-
200a or miR-200c, allowed to invade into a thick layer of collagen,
and imaged using confocal microscopy. As we have observed
previously [1], different melanoma cell lines exhibit varying
mixtures of invaded cells with an elongated or round morphology.
Expression of miR-200c, however, significantly increased the
percentage of cells utilizing the rounded mode of invasion
(Fig. 1C). This effect on cell morphology is most pronounced by
viewing the plane perpendicular to the axis of invasion with depth
indicator coloring (Fig. 1C, right), which shows that the invaded
miR-200c-transfected cells (yellow and green) are significantly
rounder than control cells. Quantification of the proportions of cells
exhibiting different modes of invasion inside the collagen layer
reveals that miR-200c induces up to a 2-fold increase in the
proportion of invaded round cells in multiple melanoma cell lines
(Fig. 1C, because mock and scrambled results were highly similar
across experiments, only scrambled control is presented for other
experimental data.) Rounded morphology was induced by
transfection of miR-200c in multiple melanoma cell lines when
plated on top of a thick deformable layer of collagen (Fig. S2).
Interestingly, miR-200c transfection of primary human melano-
cytes, which have low levels of miR-200c (Fig. 1B), results in
adoption of a round morphology (Fig. S2).
In contrast to the results obtained with miR-200c, melanoma
cells transfected with miR-200a invaded collagen-I in an elongated
manner often associated with the formation of multiple protrusions
(Fig. 1C). This elongation-promoting effect of miR-200a was
observed in multiple melanoma lines invading into 3D collagen-I
matrices (Fig. 1C), and also in the case where cells are plated on
top of a thick collagen matrix (Fig. S3). Many papers report that
miR-200 members from different subfamilies have inhibitory
activities on cell migration or tumor-progression [9,10,11,12]. The
data presented here suggest that different miR-200 family
members do not inhibit migration but have distinct effects on
the mode of tumour cell migration when studied by invasion into a
3D collagen-I matrix, a more physiological model of the interstitial
matrix. Therefore different family members should be considered
independently of each other, as also noted by others [13,20].
Previous observations that miR-200c expression suppresses cell
migration [9,10,11,12], are difficult to reconcile with the apparent
up-regulation of miR-200 members in migratory melanoma and
melanoma cell lines. In order to examine whether miR-200 family
members affect the capacity of melanoma cells to invade, we
quantified invasion in the 3D collagen invasion assay [21],
calculating invasion index measured as a ratio of the number of
cells invaded at 50 um divided by total cells. As shown in
Figure 1D, transfection of melanoma lines with synthetic miR-
200c resulted in either no change in invasion index in the
Wm266.4 cell line, or a 2-fold activation of invasive capacity in
Wm1361 and Sbcl2. The invasion of Wm266.4 cells was strongly
promoted by miR-200a, however, and was increased 15-fold
compared to controls in conditions of reduced serum (data not
shown). No significant change in invasion was observed with miR-
200a in Wm1361 or Sbcl2. Thus while there is a clear-cut effect of
miR-200a and miR-200c on the mode of invasion in all cell lines
tested, only in some cell lines is there also an overall stimulation of
the number of invaded cells. The mechanisms underlying these
differences are unclear, but these observations show that in some
situations, miR-200 family members not only alter the mode of
invasion, but can also stimulate invasion.
Levels of miR-200 family members were compared across cell
lines in order to ascertain whether there is a simple relationship
between levels of miR-200, morphology, and mode of invasion. Of
note, Sbcl2, which invades in a highly elongated manner, has
lower levels of miR-200c as compared to Wm1361 and Wm266.4,
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morphology. Levels of miR-200a show a similar pattern to miR-
200c, suggesting that miR-200c may be the more important driver
of melanoma cell morphology. However there is no clear
correlation between miR-200 levels and morphology across a
larger panel of melanoma lines, implying that the complexity of
the network of players responsible for driving melanoma cell
plasticity is not fully appreciated. Neither is there a correlation
between levels of expression of miR-200 family members and
invasive capacity, other than in normal human melanocytes,
which have very low miR-200 levels and are not invasive. Thus
there is no simple relationship between miR-200 levels and
invasion apparent from these experiments.
miR-200c regulates MARCKS
As up-regulation of miR-200c levels in melanoma cells leads to a
shift to the rounded mode of invasion, we sought to learn how this
microRNA induces round cell morphology. A candidate target gene
list was first compiled by cross-referencing published miR-200c-
responsive genes[12,22,23] with genes previously identified to play a
role in cell shape and cancer, together with targets identified by the
in-silico prediction programs TargetScan [8] and TargetRank [24].
The Wm266.4 line was selected for studies on potential target genes
becausepreviousworkhasshownthat these cells readilyinterconvert
between rounded and elongated morphologies and invade as
mixtures of similar proportions of rounded and elongated cells
[1,3]. This plasticity makes Wm266.4 a system useful for identifying
factors regulating cell morphology and mode of invasion. Because
mRNA levels are a good indicator of microRNA activity [25,26],
quantitative PCR was performed for the candidates genes in
Wm266.4 cells transfected with miR-200c or scrambled microRNA
negative control. As shown in Figure 2A, mRNA levels of four
predicted target genes (using GAPDH levels as a control) were
decreased by miR-200c: reversion-inducing-cysteine-rich protein
Figure 1. microRNA-200 regulates morphological plasticity of melanoma cells. (A) Schematic representation of the miR-200 family. (B)
Relative levels of expression of miR-200a and -200c, normalized to the invariant miR-30b*, in melanoma cell lines compared to normal human
epidermal melanocytes. (C) Transfection of miR-200a in Wm266.4 results in an elongated morphology of cells invading into collagen, while miR-200c
transfection results in a rounded morphology (scale bars in um). Quantification of the percentage of cells with rounded morphology for melanoma
cell lines invading into collagen. (D) miR-200 family members do not inhibit melanoma cell invasion, but can promote invasion. Each experiment was
performed at least three times and representative examples are shown. Error bars represent 6 SEM; unpaired t-test *p,0.05 **p,0.01 ***p,0.001.
doi:10.1371/journal.pone.0013176.g001
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(ARHGAP19), myristoylated alanine-rich protein kinase C substrate
(MARCKS), and zinc finger E-box binding homeobox 1 (Zeb1/
TCF8), while levels of the predicted target quaking homologue
(QKI) were not affected.
In order to test whether reducing expression of any of these miR-
200c responsive genes results in rounded cell morphology, the genes
were knocked down (Fig. S4) by RNA interference using oligonucle-
otide pools and cells were plated on top of a thick layer of collagen for
imaging. While control Wm266.4 cells consist of an approximately
equal mixture of elongated and round cells under these conditions, a
2-fold increase in the percentage of rounded cells was observed in
cells transfected with MARCKS siRNA, like those transfected with
miR-200c (Fig. 2B). Importantly there was no significant change in
morphology of cells transfected with Zeb1 siRNA that has previously
been shown to result in reduced cell migration in 2D migration assays
[9]. Knockdown of GAP19 showed no statistically significant effect
on cell morphology while knockdown of RECK reduced cell
rounding suggesting that in the morphological switch driven by
miR-200c, the reduction of MARCKS levels by miR-200c is
dominant over the effects of RECK reduction.
Because it produced a robust effect on cell morphology,
MARCKS knockdown was further studied by immunoblotting
and deconvolution of the siRNA pool used in Figure 2B.
Immunoblotting confirmed that miR-200c efficiently knocks down
MARCKS at the protein level (Fig. 2A). Furthermore, four
individual siRNAs that decreased MARCKS protein levels also
induced the rounded morphology (Fig. 2C). These results are in
accordance with the demonstrated role of MARCKS in the
formation of protrusions and dynamic adhesions [27] and are
observed in Sbcl2 and Wm1361 melanoma lines as well as
Wm266.4 (Fig. S4). Thus it appears that MARCKS is a key target
of miR-200c and its reduced expression contributes to a rounded
morphology.
MARCKS has multiple predicted miR-200c binding sites
(Fig. 2D). In order to identify a possible relationship between
MARCKS and miR-200c levels in melanoma, MARCKS levels
were investigated in the melanoma cell line panel and normal
melanocytes plated on a physiologic collagen matrix. As shown in
Figure 2D, MARCKS is down-regulated in most melanoma lines
compared to control melanocytes, demonstrating the opposite
relationship to that seen for miR-200c (Fig. 1B). Notably Skmel28,
Figure 2. microRNA-200c regulates MARCKS. (A) The effect of miR-200c transfection on mRNA levels of predicted target genes in Wm266.4
melanoma cells was assessed using GAPDH as a control. Lower panel: immunoblot of MARCKS expression. (B) Brightfield imaging and morphological
quantification of Wm266.4 cells transfected with siRNAs targeting miR-200c-responsive genes. (C) MARCKS knock-down by four individual siRNAs
leads to rounded cell shape in Wm266.4 cells. (D) Levels of MARCKS mRNA in melanoma cell lines and normal melanocytes, measured by qPCR and
normalized to levels of GAPDH. Error bars represent 6 SEM; unpaired t-test *p,0.05 **p,0.01.
doi:10.1371/journal.pone.0013176.g002
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morphology on collagen, and is the melanoma line with the lowest
level of microRNA-200c. However, the reciprocal relationship of
increased miR-200c and decreased MARCKS levels compared to
control melanocytes only reaches statistical significance for
Skmel2, and Wm3670. This suggests that there are additional
players to miR-200c that are contributing to MARCKS
regulation.
In order to examine the effects of MARCKS over-expression, a
previously published MARCKS-gfp construct [27] was transfected
into Wm266.4 cells. Cells that express the fusion construct plated
on a thick layer of pliable collagen matrix had a more elongated
shape than cells transfected with a GFP control plasmid (Fig. 3),
further supporting the role of MARCKS in modulating melanoma
cellular morphology.
miR-200a targets
Unlike miR-200c, transfection of miR-200a led to a switch to
elongated morphology and mode of invasion. Initial tests were
performed to assess the effect of miR-200a transfection on mRNA
levels of potential targets. Genes with putative miR-200a targeting
sequences that have been implicated in cell migration and cancer
include Abelson murine leukemia viral oncogene homolog 2
(Abl2), deleted in liver cancer 1 (Dlc1), Eph receptor A7 (EphA7),
and Zeb1. Transfection of Wm266.4 cells with either scrambled
control or miR-200a shows that miR-200a down-regulates Abl2,
Dlc1, and Zeb1, but not EphA7, as measured by quantitative PCR
(Fig. 4A). Zeb1 knockdown results in no statistically significant
change in cell morphology and attempts at siRNA targeting of
Abl2 and Dlc1 produced inconclusive data on cellular morphology
due to confounding off-target effects (data not shown).
Actomyosin contractility is an important determinant of tumor
cell morphology and is regulated by myosin light chain (MLC2)
phosphorylation [1]. Tumour cells with high levels of actomyosin
contractility have a round morphology in 3D collagen matrices
and inhibition of signaling to MLC phosphorylation or direct
inhibition of myosin II by blebbistatin leads to an elongated
morphology [1,28]. In order to determine whether miR-200a
regulates cell shape through modulation of actomyosin contrac-
tility, levels of MLC2 phosphorylation were examined in lysates of
Wm266.4 cells transfected with miR-200a or scrambled oligonu-
cleotides and plated on a thick layer of collagen. As shown in
Figure 3. MARCKS expression leads to protrusion formation in melanoma cells. Images of GFP-MARCKS or GFP expressing Wm266.4 cells
plated on a thick layer of collagen-I. Error bars represent 6 SEM; unpaired t-test **p,0.01.
doi:10.1371/journal.pone.0013176.g003
Figure 4. miR-200a associated elongation is associated with
decreased actomyosin contractility. (A) The effect of miR-200a
transfection on mRNA levels was measured for predicted target genes
in Wm266.4 melanoma cells using GAPDH as a control. (B) Transfection
of Wm266.4 cells with miR-200a leads to decreased pMLC levels.
doi:10.1371/journal.pone.0013176.g004
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phosphorylated MLC2, suggesting that this microRNA may be
promoting an elongated phenotype via reducing actomyosin
contractility.
Discussion
The results presented here suggest that the miR-200 family of
microRNAs regulates melanoma cell morphology and associated
invasion, and that functional differences exist between different
miR-200 family members. Deregulation of miR-200 expression
has been observed in multiple cancer studies, and this group of
microRNAs has been shown to be up-regulated in some, but
down-regulated in other types of cancer. The majority of
functional studies, particularly in breast cancer have concentrated
on roles of down-regulation, suggesting that miR-200 members
prevent tumor progression by negatively regulating Zeb transcrip-
tional repressors [9,10,11,12] and consequently maintaining E-
cadherin junctions and preventing EMT. Up-regulation of miR-
200 members has however been identified in cancer of the ovaries
[17], cervix [29], bowel [18], melanocyte lineage [14,15,16], bile
duct [30], and prostate [31] as well as in cancer models
[32,33,34,35]. These findings suggest that miR-200 regulation
and activity may be highly context-dependent and that miR-200
may be promoting progression of some cancers. Two recent
papers lend weight to this argument in showing that cell
proliferation in culture [36] and metastasis in vivo [37] are
promoted by miR-200 expression. The data presented here
supports a role for the miR-200 family in melanoma cell invasion
as both miR-200a and miR-200c are up-regulated in melanoma
lines and drive different modes of invasion into a physiologic
collagen-I matrix.
Two miR-200 seed classes have been identified for the two
subfamilies, miR-200bc/429 and miR-200a/141, based on one
non-identical base within the seed region (Fig. 1A), and distinctive
target predictions for these subfamilies are produced by algorithms
such as TargetScan which take into account conservation of
microRNA-target UTR complementarity across species. However,
many reports have shown the different members of the miR-200
family have similar effects on epithelial-mesenchymal transition
(e.g. through the coordinated repression of Zeb proteins)
[9,10,11,12]. Recently functional differences between these
subclasses of miR-200 have been identified [13,20], and our
findings demonstrate that miRs from different subfamilies have
dramatically different effects on cellular morphology in 3D
collagen invasion assays. Thus variation in the expression of
miR-200 family members in melanoma could lead to plasticity of
cell morphology and of mode of migration, conferring on tumor
cells the capacity to cope with different milieus in the tumor
microenvironment. Previous work shows that the rounded mode of
cell movement is favoured at the edge of tumors while within the
tumor, tumor cells move in an elongated fashion [1]. The ability of
miR-200 to regulate morphological plasticity may be important
after dissemination from the tumor as it has been shown that miR-
200c levels are different in melanoma samples located at primary
versus distant metastatic sites [15].
We show that expression of miR-200c in melanoma cells drives
the rounded-amoeboid form of cell migration and MARCKS
down-regulation. MARCKS is a peripheral membrane protein
whose translocation to the cytosol is mediated by PKC-dependent
phosphorylation [38]. The PKC-MARCKS axis has been shown
to promote dendritic spine formation in hippocampal neurons [39]
and formation of protrusive adhesions in the highly motile
Wm1617 melanoma line [27]. We show MARCKS knockdown
- using transfection of siRNA or of miR-200c - inhibits protrusion
formation and results in rounded ‘‘amoeboid’’ morphology. These
results with knockdown of MARCKS parallel our previous
observations with inhibiting signalling by Rac or its effector
WAVE2; inhibition of Rac-driven protrusions results in a round
morphology and conversion to the rounded ‘‘amoeboid’’ mode of
migration [1]. Thus there seems to be a very tight coupling
between inhibiting protrusion formation and adoption of the
rounded ‘‘amoeboid’’ mode of migration. Interestingly MARCKS
is inactivated in small intestinal adenocarcinoma [40] and
decreased MARCKS levels are observed in transformed cell lines
[41]. Moreover, over-expression of MARCKS in cancer cells
results in decreased proliferation [42] while knockdown has been
shown to increase migration [43].
We also show that invasion is not inhibited by miR-200 family
members in a physiologic 3D matrix environment, which is in
contrast to observations of others using rigid transwell migration
chambers [9,10,11,12]. In contrast to transwell studies where cells
have to migrate through a pore in a rigid membrane thinly coated
with a matrix protein, we have used thick deformable collagen-I
matrices where cells can adopt either the rounded ‘‘amoeboid-
type’’ of movement or elongated mesenchymal-type mode of
movement [1,4]. The conditions of the 3D assay are more akin to
migration through the interstitial environment because the cells
are surrounded by matrix and the deformability of the matrix
means that cells can use their contractile force to deform and
squeeze through the matrix [1,4]. Interestingly in the 3D assay
miR-200a and miR-200c can enhance invasion in some cell lines
(Fig. 1D). Since both miR-200a and miR-200c can enhance
invasion but have opposite effects on morphology it is clear that
there is no simple relationship between mode of invasion and total
invasion.
Preliminary studies to find targets of miR-200a have identified
multiple genes that are targeted by this microRNA (Fig. 4A), and
represent potential mediators of the miR-200a-induced effects
observed in culture. Previous reports have shown that MLC2
phosphorylation is associated with the rounded cell morphology
[1,28], and our finding that phosphorylation of MLC2 is altered
by miR-200a suggests actomyosin contractility is regulated by
miR-200a (Fig. 4B). As previously shown [1,44], actomyosin
contractility and rounded cell morphology are positively regulated
by RhoA-dependent ROCK signalling. This axis also inhibits
Rac-associated protrusive migration, and thus the Rho/Rac
system may represent a direct or indirect target of miR-200a.
It would be desirable to knockdown these microRNAs to further
demonstrate their role in invasion and cellular morphology,
however thus far, multiple attempts at miR-200 knockdown - using
synthetic and expression-based methods - have proven unsuccess-
ful. Quantitative PCR analysis revealed that treatment with
inhibitors towards miR-200c, for example, fails to efficiently
knockdown the microRNA, as assessed by mRNA levels of the
miR-200c-targets Zeb1 and MARCKS (data not shown). It has
been noted that miR-200b-induced rounding in colon cancer cells
was refractory to microRNA antagonists [6], and perhaps it is
difficult to achieve microRNA knockdown in some cell lines. The
data presented here nevertheless support a role of miR-200, which
is over-expressed in melanoma, in promoting melanoma cell
plasticity and associated invasion.
It is interesting that the miR-200 family seems to be up-
regulated and promoting tumor progression in some circumstanc-
es, yet down-regulated in others. Tissue of origin may account for
this observation, however another possibility is that miR-200
performs this dual-act within the same type of cancer. Previous
studies have focused primarily on the epithelial-mesenchymal
MiR-200 and Cell Morphology
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off from epithelial and E-cadherin-based tumor structures, while
our studies model different modes of single-cell invasion. It is
possible that miR-200 levels are differentially regulated at different
times in tumor progression, facilitating distinct outcomes.
In conclusion, we find the miR-200 family can play multiple
roles in cancer including promotion of invasion and switching
between modes of invasion. Additionally, our data show that miRs
from different miR-200 subfamilies have opposing effects on
morphological modes of invasion, highlighting novel distinguishing
activities of individual miR-200 family members in melanoma.
Methods
Cell Culture
Normal human epidermal melanocytes (Invitrogen C-102-5C)
were grown in 254 Media (Invitrogen M-254-500) and supplement
(Invitrogen S-002-5). A375P and A375M2 cells were obtained from
Dr R. Hynes (Howard Hughes Medical Institute, Massachusetts
Institute of Technology). SkMel2, SkMel28, Sbcl2, Wm1361,
Wm1366, Wm266.4, Wm3629, Wm3670, and 501Mel were
obtained from Drs. I Arozarena and R Marais (Institute of Cancer
Research, London). Melanoma lines were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal calf serum.
A 50:50 mixture of supplemented 254 media and DMEM-10% was
used for the miR-200c transfection of melanocytes.
Transfection
Individual and pooled siGENOME siRNAs (Dharmacon) and
Pre-miR
TM miRNA Precursor Molecules and scrambled negative
control #1 (Ambion) were diluted to 10nM in Opti-Mem
(Invitrogen) and stabilized with INTERFERin (Polyplus) prior to
transfection onto cells containing DMEM with 10% serum.
Plasmid transfection of GFP-MARCKS – a generous donation
from Dr. Karl Pfenninger [27] – and miR-200 transfection of
normal melanocytes were performed using Lipofectamine2000
and Lipofectamine (Invitrogen), respectively, following the man-
ufacturer’s protocol.
Cell Culture on Collagen
Fibrillar bovine dermal Purecol collagen (Nutacon) was
prepared at a 1.7 mg/ml dilution and 300 ul was placed in wells
of 24-well plates and allowed to polymerize at 37C for 3 hours or
overnight. The thin coating was obtained by aspirating all but a
thin film of collagen from the well before polymerization. Cells
were seeded on top of collagen in medium containing 10% serum
and allowed to adhere for 24 hr, at which point media was
switched for DMEM with 1% serum. Except where indicated, all
cell imaging, immunoblotting, and RNA isolation was performed
on cells cultured on a thick layer of collagen.
RNA Isolation, Measurement and Quantitative PCR
RNA was harvested using Trizol (Invitrogen) according to the
manufacturer’s instructions. Quantification of total RNA was
performed using a Nanodrop spectrophotometer (Thermo Scien-
tific, UK). Analysis of specific microRNA levels was performed
following the manufacturer’s instructions using TaqMan Micro-
RNA Reverse Transcription Kit, and TaqMan 2x Universal PCR
Master Mix, No AmpErase UNGb (Applied Biosystems PN
4366596 & PN 4324018). Specific microRNA primers used were
for miR-200a, miR-200c, and miR-30b* (Applied Biosystems
000502 4427975, 002300 4395411, and 002129 4395240). The
Quantitect SYBR Green RT-PCR system was used for analysis of
mRNA transcript levels, according to the manufacturer’s instruc-
tions (Qiagen). GAPDH was measured as the mRNA loading
control (Qiagen QT01192646).
Antibodies & Immunoblotting
Antibodies used in the study included: MARCKS (Santa Cruz
sc-6455), p-Thr18/Ser19-MLC2 (Cell Signalling 3674S), MLC
total (Sigma), GAPDH (Novus NB300-221). Lysates were
fractionated by SDS-PAGE and transferred to nitrocellulose
membranes. Western blotting was performed with the ECL Plus
detection System (GE Healthcare) with horseradish peroxidase-
conjugated secondary antibodies (Sigma) or using a fluorescent
secondaries and imaging system (Li-Cor). For p-Thr18/Ser19-
MLC2 detection, whole-cell extracts from cells on collagen were
harvested in Laemmli sample buffer and sonicated for 15 s prior to
centrifugation.
Invasion
The 3-dimensional collagen invasion assay was performed as
described [1,21]. DMEM media with 5% serum was used for
stimulus. Invasion is measured as a ratio of cells invaded to 50 um
over total cells.
3-Dimensional Confocal Imaging
For 3-dimensional imaging of invaded cells, the invasion assay
was performed as above except it was set up in ibiTreat u-Plate 96-
well plates (Ibidi 89626). Z-stacks of GFP-expressing invading cells
were obtained by indirect immunofluorescence microscopy using a
Zeiss LSM710 confocal microscope. Three-dimensional recon-
structions were made with Zen software (Zeiss). For evaluation of
the percentage of elongated cells invading, a cell was considered
elongated when its longest dimension was twice the shortest and
when it showed at least one protrusion.
microRNA Target Prediction
TargetScan [8] and TargetRank [24] were used to predict
microRNA targets.
Statistical Analysis
All experiments were repeated at least 3 times and represen-
tative data/images are shown. Student’s t test was performed to
determine statistical significance. Error bars indicate +SEM.
Supporting Information
Figure S1 miR-30b* serves as a control for microRNA
expression. Expression levels of miR-30b*, standardized to total
RNA measured by Nanodrop spectrophotometry, in melanoma
cell lines and normal human melanocytes.
Found at: doi:10.1371/journal.pone.0013176.s001 (0.39 MB
TIF)
Figure S2 Rounded cell morphology is induced by miR-200c in
melanoma cell lines and normal human melanocytes plated on a
thick collagen matrix. Cells was transfected with either a negative
control or miR-200c, plated on a thick collagen matrix, and
examined for morphology. (A) Left Panel: Brightfield images of
Wm266.4 cells. Right Panel: Quantification of the fraction of
round cells following transfection with miR-200c in 7 melanoma
cell lines. Error bars represent 6 SEM; unpaired t-test *p,0.05,
**p,0.005, ***p,0.0001. (B) Brightfield images of normal human
melanocytes.
Found at: doi:10.1371/journal.pone.0013176.s002 (1.86 MB
TIF)
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PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13176Figure S3 miR-200a induces elongation in melanoma cell lines
on a thick collagen matrix. Cells were transfected with either a
negative control or miR-200a, plated on a thick collagen matrix,
and examined for morphology. Upper panel: Brightfield images of
Wm266.4 cells. Lower: Quantification of the fraction of round
cells following transfection with miR-200a in 7 melanoma cell
lines. Error bars represent 6 SEM; unpaired t-test *p,0.05,
***p,0.0005.
Found at: doi:10.1371/journal.pone.0013176.s003 (1.78 MB TIF)
Figure S4 siRNA knockdown of miR-200c targets. (A) Quan-
titative PCR analysis, using GAPDH as a control, confirms gene
knockdown by siRNAs in Wm266.4 cells imaged in Figure 2. (B)
Upper: Quantification of the fraction of rounded cells following
knockdown of MARCKS by siRNA or miR-200c, in Wm1361
and Sbcl2 melanoma cell lines. Lower panel: immunoblot of
MARCKS expression following transfection of miR-200c or
siRNA targeting MARCKS.
Found at: doi:10.1371/journal.pone.0013176.s004 (0.65 MB TIF)
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